In a pivotal ruling, the High Court in London has sided with Moderna in a patent dispute against Pfizer and BioNTech over their COVID-19 vaccines. The court found that Pfizer-BioNTech’s use of mRNA technology infringed on Moderna’s patented process involving modified RNA. Despite Pfizer and BioNTech’s arguments, the court upheld
CureVac is suing BioNTech for stealing mRNA vaccine technology. After trying to create its own COVID-19 vaccine, CureVac is bringing four patent infringement claims against fellow German mRNA pioneer BioNTech.
A new vaccine “tailored” to target next-generation Covid-19 coronavirus will likely be needed by the middle of 2022, according to the head of BioNTech, the biotechnology company that developed the Pfizer shot.
According to the co-founder of BioNTech Dr Ugur Sahin, the COVID-19 vaccine he designed for Pfizer was designed in just few hours in a single day on January 25, 2020. No other vaccine in history has been created and manufactured so quickly. Previously, the fastest vaccine ever developed took more
